Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)

Introduction and Objectives: Non-invasive tests (NITs) identifying high-risk MASLD in primary care is suggested but, these strategies cost-effectiveness remain uncertain in the United Kingdom (UK). Materials and Methods: A cost-utility/budget impact model was developed for cost-effectiveness evaluat...

Full description

Saved in:
Bibliographic Details
Main Authors: Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268125000134
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items